Antiviral therapy is the key to the treatment of chronic hepatitis B. However, antiviral therapy is a long-term process. Many patients do not have sufficient psychological preparation for long-term treatment, so treatment is often interrupted, resulting in treatment failure. For this reason, Dr. Clove summed up the four misunderstandings that hepatitis B patients should know in antiviral treatment, corrected some misunderstandings, and hoped that patients would increase their confidence and patience in antiviral treatment, achieve the success of treatment as soon as possible, and recover their health. Myth 1: Virus Inhibition ≠ Virus Removal The primary goal of hepatitis B antiviral drugs is to inhibit the replication of the virus. Nucleoside (acid) drugs can [pretend] to be nucleosides needed for Read More …